A Novel Small Molecule Oral Therapeutic to Prevent and Reverse Skeletal Muscle Atrophy in Aging Adults

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/238/31/24

Funding

  • Ridgeline Therapeutics LLC: $24,397.00